1	IL-2-mediated	il-2-mediated	_	_	_	_	_	_	_
2	cell	cell	_	_	_	_	_	_	_
3	cycle	cycle	_	_	_	_	_	_	_
4	progression	progression	_	_	_	_	_	_	_
5	and	and	_	_	_	_	_	_	_
6	inhibition	inhibition	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	apoptosis	apoptosis	_	_	_	_	_	_	_
9	does	do	_	_	_	_	_	_	_
10	not	not	_	_	_	_	_	_	_
11	require	require	_	_	_	_	_	_	_
12	NF-kappa	NF-kappa	_	_	_	_	_	_	_
13	B	B	_	_	_	_	_	_	_
14	or	or	_	_	_	_	_	_	_
15	activating	activate	_	_	_	_	_	_	_
16	protein-1	protein-1	_	_	_	_	_	_	_
17	activation	activation	_	_	_	_	_	_	_
18	in	in	_	_	_	_	_	_	_
19	primary	primary	_	_	_	_	_	_	_
20	human	human	_	_	_	_	_	_	_
21	T	t	_	_	_	_	_	_	_
22	cells	cell	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	IL-2	il-2	_	_	_	_	_	_	_
3	growth	growth	_	_	_	_	_	_	_
4	hormone	hormone	_	_	_	_	_	_	_
5	is	be	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	major	major	_	_	_	_	_	_	_
8	growth	growth	_	_	_	_	_	_	_
9	factor	factor	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	activated	activate	_	_	_	_	_	_	_
12	T	t	_	_	_	_	_	_	_
13	lymphocytes	lymphocyte	_	_	_	_	_	_	_
14	during	during	_	_	_	_	_	_	_
15	a	a	_	_	_	_	_	_	_
16	developing	develop	_	_	_	_	_	_	_
17	immune	immune	_	_	_	_	_	_	_
18	response	response	_	_	_	_	_	_	_
19	.	.	_	_	_	_	_	_	_

1	IL-2	il-2	_	_	_	_	_	_	_
2	is	be	_	_	_	_	_	_	_
3	required	require	_	_	_	_	_	_	_
4	not	not	_	_	_	_	_	_	_
5	only	only	_	_	_	_	_	_	_
6	for	for	_	_	_	_	_	_	_
7	cell	cell	_	_	_	_	_	_	_
8	cycle	cycle	_	_	_	_	_	_	_
9	progression	progression	_	_	_	_	_	_	_
10	but	but	_	_	_	_	_	_	_
11	also	also	_	_	_	_	_	_	_
12	to	to	_	_	_	_	_	_	_
13	protect	protect	_	_	_	_	_	_	_
14	Ag-activated	ag-activated	_	_	_	_	_	_	_
15	T	t	_	_	_	_	_	_	_
16	cells	cell	_	_	_	_	_	_	_
17	from	from	_	_	_	_	_	_	_
18	programmed	program	_	_	_	_	_	_	_
19	cell	cell	_	_	_	_	_	_	_
20	death	death	_	_	_	_	_	_	_
21	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	several	several	_	_	_	_	_	_	_
3	cell	cell	_	_	_	_	_	_	_
4	types	type	_	_	_	_	_	_	_
5	,	,	_	_	_	_	_	_	_
6	activation	activation	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	NF-kappa	NF-kappa	_	_	_	_	_	_	_
9	B	B	_	_	_	_	_	_	_
10	and/or	and/or	_	_	_	_	_	_	_
11	activating	activate	_	_	_	_	_	_	_
12	protein-1	protein-1	_	_	_	_	_	_	_
13	(	(	_	_	_	_	_	_	_
14	AP-1	ap-1	_	_	_	_	_	_	_
15	)	)	_	_	_	_	_	_	_
16	has	have	_	_	_	_	_	_	_
17	been	be	_	_	_	_	_	_	_
18	demonstrated	demonstrate	_	_	_	_	_	_	_
19	to	to	_	_	_	_	_	_	_
20	be	be	_	_	_	_	_	_	_
21	extremely	extremely	_	_	_	_	_	_	_
22	important	important	_	_	_	_	_	_	_
23	in	in	_	_	_	_	_	_	_
24	blocking	block	_	_	_	_	_	_	_
25	apoptosis	apoptosis	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

1	To	to	_	_	_	_	_	_	_
2	determine	determine	_	_	_	_	_	_	_
3	whether	whether	_	_	_	_	_	_	_
4	either	either	_	_	_	_	_	_	_
5	or	or	_	_	_	_	_	_	_
6	both	both	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	these	these	_	_	_	_	_	_	_
9	transcription	transcription	_	_	_	_	_	_	_
10	factors	factor	_	_	_	_	_	_	_
11	are	be	_	_	_	_	_	_	_
12	involved	involve	_	_	_	_	_	_	_
13	in	in	_	_	_	_	_	_	_
14	cell	cell	_	_	_	_	_	_	_
15	survival	survival	_	_	_	_	_	_	_
16	or	or	_	_	_	_	_	_	_
17	cell	cell	_	_	_	_	_	_	_
18	cycle	cycle	_	_	_	_	_	_	_
19	progression	progression	_	_	_	_	_	_	_
20	in	in	_	_	_	_	_	_	_
21	response	response	_	_	_	_	_	_	_
22	to	to	_	_	_	_	_	_	_
23	IL-2	il-2	_	_	_	_	_	_	_
24	,	,	_	_	_	_	_	_	_
25	primary	primary	_	_	_	_	_	_	_
26	human	human	_	_	_	_	_	_	_
27	T	t	_	_	_	_	_	_	_
28	cells	cell	_	_	_	_	_	_	_
29	responsive	responsive	_	_	_	_	_	_	_
30	to	to	_	_	_	_	_	_	_
31	the	the	_	_	_	_	_	_	_
32	growth	growth	_	_	_	_	_	_	_
33	factor	factor	_	_	_	_	_	_	_
34	were	be	_	_	_	_	_	_	_
35	analyzed	analyze	_	_	_	_	_	_	_
36	for	for	_	_	_	_	_	_	_
37	NF-kappa	NF-kappa	_	_	_	_	_	_	_
38	B	B	_	_	_	_	_	_	_
39	and	and	_	_	_	_	_	_	_
40	AP-1	ap-1	_	_	_	_	_	_	_
41	activation	activation	_	_	_	_	_	_	_
42	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	current	current	_	_	_	_	_	_	_
3	study	study	_	_	_	_	_	_	_
4	clearly	clearly	_	_	_	_	_	_	_
5	demonstrates	demonstrate	_	_	_	_	_	_	_
6	that	that	_	_	_	_	_	_	_
7	IL-2	il-2	_	_	_	_	_	_	_
8	does	do	_	_	_	_	_	_	_
9	not	not	_	_	_	_	_	_	_
10	induce	induce	_	_	_	_	_	_	_
11	I	i	_	_	_	_	_	_	_
12	kappa	kappa	_	_	_	_	_	_	_
13	B	B	_	_	_	_	_	_	_
14	alpha	alpha	_	_	_	_	_	_	_
15	degradation	degradation	_	_	_	_	_	_	_
16	or	or	_	_	_	_	_	_	_
17	NF-kappa	NF-kappa	_	_	_	_	_	_	_
18	B	B	_	_	_	_	_	_	_
19	activation	activation	_	_	_	_	_	_	_
20	in	in	_	_	_	_	_	_	_
21	primary	primary	_	_	_	_	_	_	_
22	human	human	_	_	_	_	_	_	_
23	T	t	_	_	_	_	_	_	_
24	cells	cell	_	_	_	_	_	_	_
25	that	that	_	_	_	_	_	_	_
26	respond	respond	_	_	_	_	_	_	_
27	to	to	_	_	_	_	_	_	_
28	IL-2	il-2	_	_	_	_	_	_	_
29	by	by	_	_	_	_	_	_	_
30	entering	enter	_	_	_	_	_	_	_
31	the	the	_	_	_	_	_	_	_
32	cell	cell	_	_	_	_	_	_	_
33	cycle	cycle	_	_	_	_	_	_	_
34	and	and	_	_	_	_	_	_	_
35	avoiding	avoid	_	_	_	_	_	_	_
36	apoptosis	apoptosis	_	_	_	_	_	_	_
37	.	.	_	_	_	_	_	_	_

1	Similarly	similarly	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	IL-2	il-2	_	_	_	_	_	_	_
4	neither	neither	_	_	_	_	_	_	_
5	activates	activate	_	_	_	_	_	_	_
6	JNK	JNK	_	_	_	_	_	_	_
7	nor	nor	_	_	_	_	_	_	_
8	increases	increase	_	_	_	_	_	_	_
9	AP-1	ap-1	_	_	_	_	_	_	_
10	binding	binding	_	_	_	_	_	_	_
11	activity	activity	_	_	_	_	_	_	_
12	to	to	_	_	_	_	_	_	_
13	a	a	_	_	_	_	_	_	_
14	consensus	consensus	_	_	_	_	_	_	_
15	o-tetradecanoylphorbol	o-tetradecanoylphorbol	_	_	_	_	_	_	_
16	13-acetate	13-acetate	_	_	_	_	_	_	_
17	(	(	_	_	_	_	_	_	_
18	TPA	TPA	_	_	_	_	_	_	_
19	)	)	_	_	_	_	_	_	_
20	response	response	_	_	_	_	_	_	_
21	element	element	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	On	on	_	_	_	_	_	_	_
2	the	the	_	_	_	_	_	_	_
3	other	other	_	_	_	_	_	_	_
4	hand	hand	_	_	_	_	_	_	_
5	,	,	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	growth	growth	_	_	_	_	_	_	_
8	factor	factor	_	_	_	_	_	_	_
9	does	do	_	_	_	_	_	_	_
10	induce	induce	_	_	_	_	_	_	_
11	the	the	_	_	_	_	_	_	_
12	activation	activation	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	STAT3	STAT3	_	_	_	_	_	_	_
15	and	and	_	_	_	_	_	_	_
16	STAT5	STAT5	_	_	_	_	_	_	_
17	in	in	_	_	_	_	_	_	_
18	these	these	_	_	_	_	_	_	_
19	cells	cell	_	_	_	_	_	_	_
20	,	,	_	_	_	_	_	_	_
21	as	as	_	_	_	_	_	_	_
22	has	have	_	_	_	_	_	_	_
23	been	be	_	_	_	_	_	_	_
24	previously	previously	_	_	_	_	_	_	_
25	demonstrated	demonstrate	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

1	These	these	_	_	_	_	_	_	_
2	data	datum	_	_	_	_	_	_	_
3	show	show	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	neither	neither	_	_	_	_	_	_	_
6	NF-kappa	NF-kappa	_	_	_	_	_	_	_
7	B	B	_	_	_	_	_	_	_
8	nor	nor	_	_	_	_	_	_	_
9	AP-1	ap-1	_	_	_	_	_	_	_
10	activation	activation	_	_	_	_	_	_	_
11	is	be	_	_	_	_	_	_	_
12	required	require	_	_	_	_	_	_	_
13	for	for	_	_	_	_	_	_	_
14	IL-2-mediated	il-2-mediated	_	_	_	_	_	_	_
15	survival	survival	_	_	_	_	_	_	_
16	or	or	_	_	_	_	_	_	_
17	cell	cell	_	_	_	_	_	_	_
18	cycle	cycle	_	_	_	_	_	_	_
19	progression	progression	_	_	_	_	_	_	_
20	in	in	_	_	_	_	_	_	_
21	activated	activate	_	_	_	_	_	_	_
22	primary	primary	_	_	_	_	_	_	_
23	human	human	_	_	_	_	_	_	_
24	T	t	_	_	_	_	_	_	_
25	cells	cell	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

